BioSpace News Archive

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 at 8:45am ET in New York.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today provides preliminary unaudited fourth quarter and full year 2019 product sales for GOCOVRI® (amantadine) extended release capsules and outlines key business priorities for 2020.

TraceLink Inc., a network-based platform company with the world’s largest integrated digital supply network for life sciences, today announced that Shabbir Dahod, president and CEO of TraceLink, will present at the 38th Annual J.P. Morgan Healthcare Conference for the fourth consecutive year.

Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received $1,345,871 from the early exercise of previously issued warrant

Cellect Biotechnology Ltd. (Nasdaq: APOP) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of stem cells, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,000,000 American Depositary Shares (“ADSs”),

Comprehensive Outcomes Management Technologies, LLC (COMT) and Prime Health Services, Inc. (Prime Health) enter into a partnership on a specialty outcomes-based network effective today.

The National Kidney Foundation’s Board of Directors member Dr. Matthew Cooper will testify on Wednesday, January 8th before the U.S. House Energy and Commerce Health Subcommittee to support H.R. 5534, a bill which would make immunosuppressive drug coverage available to all kidney transplant patients and remove the 36-month limit for Medicare coverage currently in place.

Symmetry Surgical, Inc. (“Symmetry”), is pleased to announce that it has completed its acquisition of The O.R. Company.

Infiniti Research is a leading provider of market intelligence services to businesses around the globe.

Often known as “forgotten patients,” many childhood cancer survivors face long-term side effects and medical complications post-treatment.